TYPENEX NOTE SETTLEMENT AGREEMENTNote Settlement Agreement • October 24th, 2016 • Panther Biotechnology, Inc. • Services-engineering, accounting, research, management • Utah
This Note Settlement Agreement (this “Agreement”) is entered into as of October 5, 2016 (the “Effective Date”) by and between Typenex Co-Investment, LLC, a Utah limited liability company (“Lender”), and Panther Biotechnology, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defined below). Each of Borrower and Lender is sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
